ORDER
REPRINTS
First Synthesis of a Trisaccharide of Glycosylkaemferide
243
Phenyl 3-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranose 5.
1
[a]25D 260.08 (c, 0.05, CHCl3); M.p.: 127.5–128.08C; H NMR (CDCl3) d
2.58 (1H, d, J 2.4 Hz, OH), 3.47–3.71 (4H, m, H2–H5), 3.79 (1H, t,
J ¼ 10.2 Hz, H6a), 4.38 (1H, dd, J ¼ 10.2, 5.0 Hz, H6b), 4.62 (1H, d, J 9.2 Hz,
H1), 4.78 (1H, d, J ¼ 11.4 Hz, CH2Ph), 4.95 (1H, d, J ¼ 11.4 Hz, CH2Ph),
5.56 (1H, s, CHPh), 7.24–7.54 (15H, m, 3Ph); 13C NMR (CDCl3) d 68.6, 70.7,
72.2, 74.8, 81.1, 81.6, 88.4, 101.2, 126.0–138.1; CIMS: m/z 451 [Mþ þ 1].
2,3,4,6-Tetra-O-acetyl-a-D-glucopyranosyl trichloroacetimidate 7.
1
[a]27D þ52.08 (c, 0.001, CHCl3); H NMR (CDCl3) d 2.02 (3H, s, CH3),
2.04 (3H, s, CH3), 2.06 (3H, s, CH3), 2.08 (3H, s, CH3), 4.13 (1H, dd,
J ¼ 12.8, 2.0 Hz, H6a), 4.20–4.24 (1H, m, H5), 4.28 (1H, dd, J ¼ 12.4,
4.0 Hz, H6b), 5.14 (1H, dd, J ¼ 10.0, 4.0 Hz, H2), 5.19 (1H, t, J ¼ 10.0 Hz,
H3), 5.57 (1H, t, J ¼ 9.6 Hz, H-4), 6.57 (1H, d, J ¼ 4.0 Hz, H1), 8.71 (1H, s,
NH); 13C NMR (CDCl3) d 20.4, 20.5, 20.6, 61.3, 67.7, 69.6, 69.8, 69.9, 92.8,
160.7, 169.4, 169.8, 169.9, 170.5; CIMS: m/z 492 [Mþ þ 1].
Phenyl
2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl-(1 ! 2)-3-O-
benzyl-1-thio-b-D-glucopyranoside 9. [a]26D 220.08 (c, 0.001, CHCl3);
M.p.: 65.5–68.58C; 1H NMR (CDCl3) d 2.01 (3H, s, CH3), 2.02 (3H, s, CH3),
3.29 (1H, m), 3.44 (1H, t, J ¼ 8.8 Hz,), 3.64 (1H, t, J ¼ 9.2 Hz,), 3.71–3.84
(3H, m), 4.09–4.14 (3H, m), 4.22 (1H, dd, J ¼ 12.4, 4.4 Hz), 4.67 (1H, d,
J ¼ 9.6 Hz) 4.83 (2H, s, CH2Ph), 5.10–5.18 (3H, m), 7.24–7.49 (10H, m, Ph);
13C NMR (CDCl3) d 20.5, 20.7, 21.0, 61.7, 62.2, 68.3, 70.8, 71.6, 71.9, 73.1,
75.6, 76.5, 79.0, 85.7, 86.7, 99.6, 127.4–137.9 (Ph), 169.1, 169.3, 170.2,
170.7; FABMS (pos.-ion): m/z 693 [Mþ þ 1].
2,3,4-Tri-O-acetyl-a-L-rhamnopyranosyl trichloroacetimidate[9] 10.
[a]27D 272.08 (c, 0.001, CHCl3); 1H NMR (CDCl3) d 1.27 (3H, d, J ¼ 5.6 Hz,
CH3), 2.00 (3H, s, CH3), 2.08 (3H, s, CH3), 2.19 (3H, s, CH3), 4.10 (1H, m,
H5), 5.18 (1H, t, J ¼ 10.4 Hz, H4), 5.37 (1H, dd, J ¼ 10.4, 3.2 Hz, H3), 5.46
(1H, dd, J ¼ 3.2, 2.0 Hz, H2), 6.20 (1H, d, J ¼ 2.0 Hz, H1) 8.74 (1H, s, NH);
13C NMR (CDCl3) d 17.4, 20.6, 20.7, 68.0, 68.7, 69.2, 70.2, 90.6, 94.6, 159.9,
169.75, 169.82; CIMS: m/z 435 [Mþ þ 1].
Phenyl 2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl-(1 ! 2)-[2,3,4-tri-
O-acetyl-a-L-rhamnopyranosyl-(1 ! 6)]-3-O-benzyl-1-thio-b-D-gluco-
pyranoside 11. [a]26D 256.08 (c, 0.001, CHCl3); M.p.: 80.2–81.08C; H
1
NMR (CDCl3) d 1.18 (3H, d, J 6.0 Hz, CH3), 2.01 (3H, s, CH3), 2.02 (3H, s,
CH3), 2.03 (3H, s, CH3), 2.04 (3H, s, CH3), 2.06 (3H, s, CH3), 2.09 (3H, s,
CH3), 2.14 (3H, s, CH3), 3.40 (1H, m) 3.52 (1H, t, J ¼ 8.8 Hz), 3.60–3.70
(3H, m), 3.82 (1H, t, J ¼ 8.8 Hz) 3.89–3.95 (2H, m), 4.06 (1H, dd, J ¼ 12.4,
2.4 Hz) 4.12 (1H, dd, J ¼ 14.4, 7.2 Hz), 4.26 (1H, dd, J ¼ 12.0, 4.4 Hz) 4.62
(1H, d, J ¼ 9.2 Hz), 4.73 (1H, s) 4.77 (1H, d, J ¼ 10.4 Hz, CH2Ph), 4.88 (1H,
d, J ¼ 11.2 Hz, CH2Ph) 5.01–5.20 (5H, m), 5.23–5.26 (2H, m) 7.22–7.52
(10H, m, Ph); 13C NMR (CDCl3) d 20.6, 20.8, 20.8, 20.9, 61.8, 66.5, 66.8,